Riviciclib

SI-7765

Riviciclib, >98% (HPLC)

CAS No. : [920113-02-6]

Synonyms : P276-00

IUPAC Name : 2-(2-Chlorophenyl)-5,7-dihydroxy-8-((2S,3R)-2-(hydroxymethyl)-1-methylpyrrolidin-3-yl)-4H-chromen-4-one

Price And Availability
Pack Size	Price in USD	Add To Shopping Cart	Availability	Shipping Status
5MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
10MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
25MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
50MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
100MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026

Applications : Riviciclib potently inhibits CDK9, CDK4, and CDK1 with IC₅₀ values of 20–79 nM. Through suppression of CDK‑dependent transcriptional and proliferative signaling, it shows strong antitumor effects, particularly in models of cisplatin‑resistant malignancies.

References : Roskoski R. Jr : Pharmacol Res., 107, 249-275, 2016; Joshi K. S. et al.: Mo.l Cancer Ther., 6(3), 918-25, 2007; Joshi K. S.et al.: Mol. Cancer Ther., 6(3), 926-34, 2007.

Storage : Keep container tightly closed under nitrogen or argon and refrigerate for long-term shelf life.

Caution : In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves.